Magenta Therapeutics

Manufacturing · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

100 Technology Sq Fl 5, Cambridge, Massa...

Revenue

$15.9 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Magenta Therapeutics

Magenta Therapeutics is focused in developing medicines to make cures possible for more patients with blood cancers, genetic diseases and autoimmune diseases.Explore more
Magenta Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Magenta Therapeutics Org Chart

PhoneEmail
JC
United States flag for contact location.

Director, Supply Chain

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Magenta Therapeutics

Compare insights from companies similar to Magenta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Magenta Therapeutics

$15.9M
1-10
Private
$396.9M
2015
JC
Jennifer CoelhoDirector, Supply Chain
$12.7M
11-50
Public
$441.5M
2017
<$5M
1-10
Public
$26M
2019
Regina Graul, President and Chief Executive Officer at Cyclerion Therapeutics
Regina GraulPresident and CEO
<$5M
11-50
Public
$420.1M
2014
Charles Carter, Chief Financial Officer at Ovid Therapeutics
Charles CarterChief Financial Officer
<$5M
1-10
Public
$27M
2011
TC
Tonya CattertonVice President, Quality & Compliance
<$5M
1-10
Public
$5M
2006
1-10
Public
$185.6M
2016
Allan Musso, Chief Financial Officer & Principal Financial Officer and Principal Accounting Officer at Fulcrum Therapeutics
Allan MussoChief Financial Officer & Principal Financial Officer and Principal Accounting Officer
Illustration of an envelope

Magenta Therapeutics Tech Stack

A closer look at the technologies used by Magenta Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Magenta Therapeutics

What is Magenta Therapeutics's official website?
Magenta Therapeutics's official website is www.magentatx.com
What is Magenta Therapeutics's Revenue?
Magenta Therapeutics's revenue is $15.9 Million
What is Magenta Therapeutics's SIC code?
Magenta Therapeutics's SIC: 28,283
What is Magenta Therapeutics's NAICS code?
Magenta Therapeutics's NAICS: 32,325
How many employees does Magenta Therapeutics have?
Magenta Therapeutics has 1-10 employees
What industry does Magenta Therapeutics belong to?
Magenta Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Magenta Therapeutics competition?
Magenta Therapeutics top competitors include: Cocrystal Pharma, Ovid Therapeutics, NexImmune, Fulcrum Therapeutics
What technology does Magenta Therapeutics use?
Some of the popular technologies that Magenta Therapeutics uses are: DocuSign, WordPress.org, PHP, Proofpoint
What does Magenta Therapeutics do?

Magenta Therapeutics is focused in developing medicines to make cures possible for more patients with blood cancers, genetic diseases and autoimmune diseases.... Read More

What are Magenta Therapeutics social media links?
Magenta Therapeutics Linkedin page Magenta Therapeutics Twitter page
Who invested in Magenta Therapeutics?
Magenta Therapeutics has 21 investors including Partners Innovation Fund, Third Rock Ventures, Atlas Ventures and Third Rock Ventures.
Is Magenta Therapeutics a public company?
Magenta Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Magenta Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.